JMKX001899

DRUG4 trials

Sponsors

Jemincare

Conditions

NSCLC (Advanced Non-small Cell Lung Cancer)NSCLC (Non-small Cell Lung Cancer)Solid Tumor, Adult

Phase 1

Study to Evaluate the Drug-drug Interaction of JMKX001899 in Healthy Subjects

Not yet recruitingNCT06348290

JemincareSolid Tumor, Adult

Start: 2024-04-01End: 2024-09-15Target: 72Updated: 2024-04-04

To Assess the Effects of Single Dose of JMKX001899 on QTc Interval in Healthy Subjects

Not yet recruitingNCT06473948

JemincareSolid Tumor, Adult

Start: 2024-07-10End: 2025-02-27Target: 27Updated: 2024-06-25

A Phase Ib Study of JMKX001899 in Combination With Other Therapies in Advanced NSCLC Harboring KRAS G12C Mutation

RecruitingNCT06946927

JemincareNSCLC (Advanced Non-small Cell Lung Cancer)

Start: 2025-06-06End: 2027-12-31Target: 72Updated: 2025-07-01

Phase 3

Phase 3 Trial of JMKX001899 Versus Docetaxel in Previously Treated Advanced or Metastatic KRAS G12C-Mutant NSCLC

Not yet recruitingNCT07242274

JemincareNSCLC (Non-small Cell Lung Cancer)

Start: 2025-12-31End: 2029-12-30Target: 472Updated: 2025-11-21